Hadi Yaziji

CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin

Robert Werling, Hadi Yaziji, Carlos E. Bacchi et al. · The American Journal of Surgical Pathology · 2003 · 718 citations

Medicine, Oncology, Pathology +17

Specificity of HercepTest in Determining <i>HER-2</i>/<i>neu</i> Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System

Timothy W. Jacobs, Allen M. Gown, Hadi Yaziji et al. · Journal of Clinical Oncology · 1999 · 459 citations · Full text

Medicine, Oncology, Pathology +15

HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods

Hadi Yaziji · JAMA · 2004 · 449 citations

Medicine, Genetics, Oncology +15

Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of <i>HER-2</i>/<i>neu</i> in Breast Cancer

Timothy W. Jacobs, Allen M. Gown, Hadi Yaziji et al. · Journal of Clinical Oncology · 1999 · 306 citations

Medicine, Cancer Biology, Oncology +17

Recommendations for Improved Standardization of Immunohistochemistry

Neal S. Goldstein, Stephen M. Hewitt, Clive R. Taylor et al. · Applied immunohistochemistry & molecular morphology · 2007 · 222 citations

Medicine, Pathology, Good Laboratory Practice +8